Penumbra, Inc. ( PEN) - Stock Earnings
PEN Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 45.9 million USD | 354.7 million USD |
| 2025Q4 | 47.3 million USD | 385.4 million USD |
| 2026Q1 | 32.6 million USD | 374.8 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
PEN Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 91.0 million USD | 1.1 billion USD |
| 2024 | 14.0 million USD | 1.2 billion USD |
| 2025 | 177.7 million USD | 1.4 billion USD |
| 2026 Est. | — | — |
PEN
Price: $318.18
52 week price:
Earnings Per Share: 4.35 USD
P/E Ratio: 74.08
Exchange: NYQ
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 268800
Ebitda: 1.8 millionMarket Capitalization: 12.6 billion